Carregant...
Advances in chimeric antigen receptor T-cell therapy for B-cell non-Hodgkin lymphoma
B-cell non-Hodgkin lymphoma (B-NHL) is a group of heterogeneous disease which remains incurable despite developments of standard chemotherapy regimens and new therapeutic agents in decades. Some individuals could have promising response to standard therapy while others are unresponsive to standard c...
Guardat en:
| Publicat a: | Biomark Res |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BioMed Central
2021
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8278776/ https://ncbi.nlm.nih.gov/pubmed/34256851 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40364-021-00309-5 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|